PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Verbal response time reveals hidden sleepiness in older adults

A new study finds that verbal reaction time can detect sleepiness, a common, often overlooked safety risk in older adults

2025-07-09
(Press-News.org) A new study led by UCLA investigators shows that Verbal Reaction Time (VRT), the amount of time it takes a person to respond verbally, can be a marker of sleepiness in older adults. The study, which measured participants’ voice data through standardized cognitive assessments, show how VRT can passively detect excessive sleepiness, especially among older individuals using sedative medications.

Why it matters

Sleepiness is a major contributor to safety risks in daily life, but is often underreported or unnoticed, especially among older adults. Excessive sleepiness contributes to motor vehicle crashes, cognitive impairment, and falls, especially in older adults using sedative medications like benzodiazepine receptor agonists (BZRAs). Current methods to assess sleepiness are often intrusive or impractical for real-world use. This study provides a scalable way to detect sleepiness to help identify at-risk individuals before accidents or health declines occur.

What the study did

Researchers studied adults aged 55 and older with a history of insomnia and BZRA use, recruited from a deprescribing clinical trial. Participants completed memory tests via a mobile app, which recorded their verbal responses. The team measured verbal reaction time (VRT), the delay between the start of recording and the first spoken word, comparing it to participants’ self-reported sleepiness. The researchers then used advanced tools to study the link between how quickly people started speaking and how sleepy they felt. They also tested whether a computer model could accurately predict someone’s sleepiness based on their voice.

What they found

The model successfully predicted participants’ self-reported sleepiness based on their voice recordings. People who took longer to start speaking after a prompt also reported feeling sleepier. The computer model used in the study was able to correctly identify different levels of sleepiness with strong accuracy, achieving an F1-score of 0.80 ± 0.08. (The F1-score is a measure of how well the model balances accuracy and consistency; 1.0 is perfect, and 0 means it failed.) The voice analysis method also reliably detected when someone was speaking versus silent, with 92.5% accuracy. The results suggest that voice timing could be a useful, low-effort way to monitor sleepiness—especially outside of clinical settings.

What’s next

The team plans to expand this approach to larger and more diverse populations and explore integration into everyday technologies like smartphones and telehealth platforms. Future research may also investigate how voice-based markers can monitor medication effects or detect early signs of cognitive decline.

From the experts

“This study shows that something as simple as how quickly someone starts speaking can tell us a lot about their level of alertness,” said Dr. Tue T. Te, lead author of the study and a researcher at the David Geffen School of Medicine at UCLA and the VA Greater Los Angeles Healthcare System. “It opens the door to using voice as a passive, scalable tool for monitoring sleepiness during everyday activities.”

About the study: Predicting subjective sleepiness during auditory cognitive testing using voice signaling analysis. Published July 1, 2025, in Sleep Science and Practice. DOI: https://doi.org/10.1186/s41606-025-00141-y

About the Research Team

Tue T. Te, Cathy Alessi, Jennifer L. Martin, Arash Naeim, Constance H. Fung David Geffen School of Medicine at UCLA; VA Greater Los Angeles Healthcare System; Sara Ghadimi, VA Greater Los Angeles Healthcare System; Mary Regina Boland, Saint Vincent College; Joseph M. Dzierzewski, National Sleep Foundation; Sarah Kremen, Cedars-Sinai Medical Center; Alex A. T. Bui, David Geffen School of Medicine at UCLA

Funding and Disclosures

The project was supported by R01 AG057929 from the National Institute on Aging of the National Institutes of Health (to CHF) and UCLA CTSI UL1 TR001881. Dr. Martin was supported by a VA HSR&D Service Research Career Scientist Award (#RCS 20-191). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Department of Veterans Affairs, or National Sleep Foundation.

END


ELSE PRESS RELEASES FROM THIS DATE:

University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life

2025-07-09
The University of Maryland School of Medicine (UMSOM) Palliative Medicine Program has launched a new clinical trial funded by the National Institute on Aging to explore a potential treatment for agitation in patients with dementia nearing the end of life. The study focuses on an investigational oral drug, T2:C100, which contains the two active ingredients in cannabis: THC and CBD. Currently, standard medications such as morphine, valium, and Haldol are commonly used to manage agitation in hospice-eligible patients with dementia. However, these treatments are often ineffective ...

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.006 This new article publication from Acta Pharmaceutica Sinica B, discusses targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery.   Triple-negative breast cancer (TNBC) is aggressive, with high recurrence rates and poor prognosis. Paclitaxel (PTX) remains a key chemotherapeutic agent for TNBC, but its efficacy diminishes due to the emergence of drug resistance, largely driven by cancer stem-like cells (CSCs), vasculogenic mimicry (VM) formation and tumor immunosuppressive ...

SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.017 This new article publication from Acta Pharmaceutica Sinica B, discusses how SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts.   Idiopathic pulmonary fibrosis (IPF), a chronic interstitial lung disease, is characterized by aberrant wound healing, excessive scarring and the formation of myofibroblastic foci. Although the role of alternative splicing (AS) in the pathogenesis of organ fibrosis has garnered increasing attention, ...

Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.001 This new article publication from Acta Pharmaceutica Sinica B, discusses how a psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis.   Ovarian tumor (OT) is the most lethal form of gynecologic malignancy, with minimal improvements in patient outcomes over the past several decades. Metastasis is the leading cause of ovarian cancer-related deaths, yet the underlying mechanisms remain poorly understood.   Psychological stress is known to activate ...

An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.008 This new article publication from Acta Pharmaceutica Sinica B, discusses how an anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 inflammasome activation.   The coinfection of respiratory viruses and bacteria is a major cause of morbidity and mortality worldwide, despite the development of vaccines and powerful antibiotics. As a macromolecule that is difficult to absorb in the gastrointestinal tract, a homogeneous polysaccharide from Houttuynia cordata (HCPM) has been reported ...

ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.018 This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.   Chemotherapy is currently the mainstay of systemic management for triple-negative breast cancer (TNBC), but chemoresistance significantly impacts patient outcomes.   This research indicates that Doxorubicin (Dox)-resistant TNBC cells exhibit increased glycolysis and ATP generation compared to their parental cells, with this metabolic shift contributing to chemoresistance. It was discovered ...

A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy

2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.007 This new article publication from Acta Pharmaceutica Sinica B, discusses how a photodynamic nanohybrid system reverses hypoxia and augments anti-primary and metastatic tumor efficacy of immunotherapy.   Photodynamic immunotherapy is a promising strategy for cancer treatment. However, the dysfunctional tumor vasculature results in tumor hypoxia and the low efficiency of drug delivery, which in turn restricts the anticancer effect of photodynamic immunotherapy.   The ...

Acta Pharmaceutica Sinica B Volume 15, Issue 6 Publishes

2025-07-09
https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/vol/15/issue/6 Acta Pharmaceutica Sinica B (APSB) was founded with the goal of creating a global high-level forum centred around drug discovery and pharmaceutical research/application. APSB was included by Chemical Abstracts in 2011, accepted by PubMed Central in 2015, indexed by Science Citation Index in 2017 and has evolved to become one of the most important international journals in the field of pharmaceutical sciences. APSB is a monthly journal, in English, which publishes ...

From injury to agony: Scientists discover brain pathway that turns pain into suffering

2025-07-09
LA JOLLA (July 9, 2025)—Pain isn’t just a physical sensation—it also carries emotional weight. That distress, anguish, and anxiety can turn a fleeting injury into long-term suffering. Researchers at the Salk Institute have now identified a brain circuit that gives physical pain its emotional tone, revealing a new potential target for treating chronic and affective pain conditions such as fibromyalgia, migraine, and post-traumatic stress disorder (PTSD). Published on July 9, 2025, in Proceedings of the National Academy of Sciences, the study identifies a group of neurons in a central brain area called the thalamus ...

Molecular simulations show graphite ‘hijacks’ diamond formation through unexpected crystallization pathways

2025-07-09
The graphite found in your favorite pencil could have instead been the diamond your mother always wears. What made the difference? Researchers are finding out. How molten carbon crystallizes into either graphite or diamond is relevant to planetary science, materials manufacturing and nuclear fusion research. However, this moment of crystallization is difficult to study experimentally because it happens very rapidly and under extreme conditions. In a new study published July 9 in Nature Communications, researchers from the University of California, Davis and George Washington ...

LAST 30 PRESS RELEASES:

Chemicals from turmeric and rhubarb could help fight antibiotic-resistant bacteria lurking in wastewater

Instant cancer diagnosis with light and AI!

New electroenzymatic strategy enables non-natural oxidation reactions

Tunable laser light

Scientists uncover magnetic-field control of ultrafast spin dynamics in 2D ferromagnets

New AI-powered model accurately predicts lung motion with minimal radiation

AI language models show promise in predicting liver cancer treatment outcomes

Tracking insect and bug health in a heartbeat from a digital camera

'Talking fish' not heard by conservation policies, SFU study warns

Thirty years of research shows increased resistance in fungi

Junk food ‘avoids advertising regulation’ with top level UK sports sponsorship

Banking on AI while committed to net zero is ‘magical thinking’, claims report on energy costs of big tech

Ancient river systems reveal Mars was wetter than we thought

Online toolkit to help parents of autistic children improve dental health

The psychological and neurological parallels between sports fandom and religious devotion

Agricultural liming in the US is a large CO2 sink, say researchers

Seaside more likely to make us nostalgic than green places, study finds

Psilocybin delays aging, extends lifespan, Emory study suggests

Buck Institute awarded DARPA contract to pioneer next-gen AI modeling platform

Orange is the new aphrodisiac—for guppies

Murals boost Cincinnati’s vitality, community development

Ad blockers may be showing users more problematic ads, NYU Tandon study finds

Verbal response time reveals hidden sleepiness in older adults

University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts

Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis

An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i

ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells

A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy

[Press-News.org] Verbal response time reveals hidden sleepiness in older adults
A new study finds that verbal reaction time can detect sleepiness, a common, often overlooked safety risk in older adults